Danon Disease Gene Therapy & TGCT Treatment Win EMA PRIME Designations
Executive Summary
Promising early clinical trial results from Rocket and Abbisko respectively helped the companies secure their places on the European Medicines Agency’s priority medicines scheme, which aims to help speed up the development and regulatory review of treatments for unmet medical needs.